- Home
- QD vs TERN Comparison
QD vs TERN Comparison
Compare QD & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QD
- TERN
- Stock Information
- Founded
- QD 2014
- TERN 2017
- Country
- QD China
- TERN United States
- Employees
- QD N/A
- TERN N/A
- Industry
- QD Finance: Consumer Services
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- QD Finance
- TERN Health Care
- Exchange
- QD Nasdaq
- TERN Nasdaq
- Market Cap
- QD 754.6M
- TERN 634.5M
- IPO Year
- QD 2017
- TERN 2021
- Fundamental
- Price
- QD $4.12
- TERN $7.40
- Analyst Decision
- QD
- TERN Buy
- Analyst Count
- QD 0
- TERN 6
- Target Price
- QD N/A
- TERN $13.99
- AVG Volume (30 Days)
- QD 392.3K
- TERN 1.1M
- Earning Date
- QD 08-13-2025
- TERN 11-11-2025
- Dividend Yield
- QD N/A
- TERN N/A
- EPS Growth
- QD N/A
- TERN N/A
- EPS
- QD 0.42
- TERN N/A
- Revenue
- QD $19,058,373.00
- TERN N/A
- Revenue This Year
- QD N/A
- TERN N/A
- Revenue Next Year
- QD N/A
- TERN N/A
- P/E Ratio
- QD $9.83
- TERN N/A
- Revenue Growth
- QD N/A
- TERN N/A
- 52 Week Low
- QD $1.77
- TERN $1.87
- 52 Week High
- QD $5.08
- TERN $10.70
- Technical
- Relative Strength Index (RSI)
- QD 44.40
- TERN 59.10
- Support Level
- QD $4.08
- TERN $7.01
- Resistance Level
- QD $4.37
- TERN $7.67
- Average True Range (ATR)
- QD 0.17
- TERN 0.42
- MACD
- QD -0.08
- TERN -0.06
- Stochastic Oscillator
- QD 5.22
- TERN 62.00
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.